Fernando Escalante

Universidad Peruana Cayetano Heredia — PE

Medicine · Health Sciences

21h-index1.7kcitations144works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(102), Protein Degradation and Inhibitors(31), Chronic Lymphocytic Leukemia Research(21), Cancer Treatment and Pharmacology(16), Peptidase Inhibition and Analysis(16)

Publications143 total

Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell Transplantation
Clinical Lymphoma Myeloma & Leukemia·2025Open Access
Efficacy and Safety of Daratumumab-Based Schemes in Over80_Years Newly Diagnosed Multiple Myeloma(NDMM)
Clinical Lymphoma Myeloma & Leukemia·2025
Efficacy and Safety of Iberdomide, Daratumumab, and Dexamethasone, in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients: Initial Analysis of the GEM-IBERDARAX trial
Clinical Lymphoma Myeloma & Leukemia·2025
Quadruplet Therapy and ASCT in Multiple Myeloma: Does It Increase Toxicity?
Clinical Lymphoma Myeloma & Leukemia·2025
Optimizing The Alcyone Trial: Efficacy Of Daratumumab And Bortezomib Maintenance In Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients Post Dvmp Induction, 2 Year Analysis
Clinical Lymphoma Myeloma & Leukemia·2025Open Access
Variables Associated With the Risk of Severe Mucositis During Autologous Transplantation in Multiple Myeloma Patients
Clinical Lymphoma Myeloma & Leukemia·2025
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis
Blood Advances·2025Open Access
Candidemia and antifungal susceptibility in Peruvian hospitals
Revista Médica Herediana·2025Open Access
Functional outcomes of arthroscopic rotator cuff repair: transosseous technique versus single-row with anchors
International Journal of Research in Orthopaedics·2025· 1 citedOpen Access
Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre Experience
Cancers·2025· 1 citedOpen Access
Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)
Blood·2024
Comparative Effectiveness of Linvoseltamab Versus Current Real-World (RW) Standard-of-Care (SOC) Therapies in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM): Key Subgroups Analysis
Blood·2024
Real-World Evidence of First-Line Therapy in Non-Transplant Eligible Multiple Myeloma Patients: Insights from the Cimma Study
Blood·2024Open Access
Real-World Evidence of First-Line Therapy in Transplant Eligible Multiple Myeloma Patients: Insights from the Cimma Study
Blood·2024Open Access
Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter Registry
HemaSphere·2024· 7 citedOpen Access
Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States
Haematologica·2024Open Access
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma
Journal of Clinical Oncology·2024· 12 cited
P-369 Optimizing the Alcyone Trial: Efficacy of Daratumumab And Bortezomib Maintenance in Non-Transplant Eligible Newly Diagnosed Multiple Myeloma Patients Post Dara-Vmp Induction, 1 Year Analysis
Clinical Lymphoma Myeloma & Leukemia·2024
P-427 Real-world Prevalence and Multi-omic Analysis of t(11;14)-Positive Multiple Myeloma: Final Analysis from the MEDICI Study
Clinical Lymphoma Myeloma & Leukemia·2024· 1 cited
P-421 Characteristics of Patients and Management of Ocular Adverse Events After Treatment With Belantamab Mafodotin (Belamaf) in Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Study in Europe
Clinical Lymphoma Myeloma & Leukemia·2024
page 1 of 8Next →

Frequent Co-authors

María‐Victoria Mateos(28), Jesús F. San Miguel(27), Noemí Puig(25), Enrique M. Ocio(23), Norma C. Gutiérrez(22), Verónica González‐Calle(21), Ramón García‐Sánz(19), Juan José Lahuerta(19), Bruno Paiva(18), Joaquín Martínez‐López(16), Albert Oriol(16), Alfonso García de Coca(14), Marta Sonia González(14), Felipe de Arriba(14), Miguel‐Teodoro Hernández(14), Javier de la Rubia(12), Abelardo Bárez(11), Joan Bladé(11), Adrían Alegre(11), Rafael Ríos(11)